Media coverage
1Media coverage
Title Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma; G-202-003 Media name/outlet Clinical Trials.gov Country United States Date 10/2/18 Persons Devalingam Mahalingam